The analysis results of Yang et al. (113) showed that in cancer patients with PD-1/PD-L1 blockade therapy, the AEs of any grade with different prevalences between Asian populations and Western/international populations included fatigue, diarrhea, nausea, rash, vomiting, and hypothyroidism. Here, PDCD1 is linked to cancer.